RA RA
Company Profile ↓Company Overview
RA (RA) is a publicly traded company listed on with a market capitalization of $640.95M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 9.8.
Maintains a net profit margin of 95.3%.
Carries low leverage with a debt-to-equity ratio of 0.33.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $64.90M (-3.9% YoY); net profit $61.88M.
- Trailing 12 Months Year-on-year growth — revenue -3.9%, earnings -3.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -3.87% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -3.90% |
Stock Price Performance
| 1 Year: | -2.10% |
| 6 Months: | -4.99% |
| 3 Months: | -6.34% |
| 1 Month: | +0.08% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.35 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 95.3%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -119.82M | 84.87M | 67.52M | 64.90M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 3.37M | 3.06M | 3.12M | 3.02M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 9.39M | 13.19M | 12.05M | 13.12M |
| Pretax Income | - | -123.18M | 81.81M | 64.39M | 61.88M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -123.18M | 81.81M | 64.39M | 61.88M |
| Diluted EPS | 2.49 | -2.15 | 1.50 | 1.18 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 1.19B | 1.00B | 1.09B | 1.06B |
| Current Assets | - | - | - | - |
| Cash & Equivalents | 3.19M | 179.28K | 2.18M | 1.70M |
| Inventory | - | - | - | - |
| Receivables | 16.90M | 12.62M | 11.94M | 12.35M |
| Total Liabilities | 318.87M | 175.57M | 277.21M | 265.97M |
| Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Total Debt | 315.57M | 169.20M | 255.66M | 260.02M |
| Total Equity | 867.73M | 828.00M | 811.50M | 795.14M |
| Shares Outstanding | 55.71M | 55.46M | 55.25M | 55.25M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 102.85M | 263.32M | -3.57M | 73.37M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -106.67M | -266.33M | 5.57M | -73.89M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 102.85M | 263.32M | -3.57M | 73.37M |
| Net Change in Cash | - | -3.82M | -3.01M | 2.00M | -518.20K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 102.8% | 96.4% | 95.4% | 95.3% |
| ROE % | - | -14.2% | 9.9% | 7.9% | 7.8% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RA
WORLD GOLD URAN & RA DIV EU (^765105-EUR-DIV) latest stock news and headlines - Yahoo Finance UK
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFB6d0I3Q2tJN3VxN1VCMEl1OUNtc3hCVnVST0M0WElIMjBqZG85THBzMnl3VmpCUU1rZVdjUlMtdERLbzZ6Y3RlSUptcmNJV0oxaVcydUlUWDVibmIzSThWcnpwbHlNTUJ5ZEE?oc=5" target="_blank">WORLD GOLD URAN & RA DIV…
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree - BioPharma Dive
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOcmNLcE1qNTJkNnVRd241c0FCU2NhSGxkUW4xVVN2TzliVVduM2FmQlgzeXktb0VxbWxzTy12cVdqbkdLWEpHR2VPNjRSOGluYjBrU0VWOFpUbGdRUlllTGpCYkN4X2gyZW9Bbkk0eDlPUmpXeHZ6Y3ZZZHE1djByTU1lYzNjVTBlOFZCan…
Lions Coach Shares Decision on Amon-Ra St. Brown After Unfortunate News - Yahoo Sports
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxONjZuVWhoYlpuOFVnQWxCUm1EamJ1aVliSkFCcVJaaWp6bTFjMjRNT1dxMTdncVllWTBURWtUb0puTUM5LTg1ZUhXUmFwdFRONGdVTDQxRXV4WXN3VDVpaC1DS2YzWWEybmF6cjlLVmgwZXFLYVNKRTBTLXVyVzIzTXVUWW50U255?oc=5"…
DBV Technologies sells $50M in stock to RA Capital via ATM program - Dealroom
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNWmdkMHpMaUk4cWpjek84MjJBSTFzcnZVRE9yaUlnY2ZmNkYwcVRzZE1LZVkzeDF5Tnd1SzRrN2k3S1A4N1JiRTZjcXh6Z0JEY3hDcmVYM1VfcnhyY2JOdmVtb0VFeURqRkNsR19USDFmLWZ1MENYSDRGTDFBd2hIZjk2cWRSQ0RoSjhXZj…
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOVzJTSWozTkVzbUJMaFBlNDZjY3BUZ3RGaHMweXRfVDJHZnYxdXF1SDIwcGlDVk1tMVpwY183ek1qY0tuUnFTblpQM1c4TEIweE9yanF1Tm4tR2xfMVdZVWtPRGdZbi1xVFpzU3FDdkpSclJramZhc2dVM0xYYUpveGE4SHNrTmlfbkZUNz…
Hong Ra-hee Gifts Samsung Shares to Lee Jae-yong - 조선일보
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTW5OM3FxUU5FU29FLVZ4T1RaV0ZjMzNoRGk1WHBjeEtnS00zSk05OE50SGNNUlZSVDdWbF9MR2ZhbEdDTUQ0MFFxVmRFZjNJbHBtSEQ4MzRuekJBNkM3MVZtckJvZUcyT28yVEJyVXFKU1BEdFhwV0pOVFdrcmtlQ1p5QmFuSkk0?oc=5"…
RA — Frequently Asked Questions
What is the current share price of RA?
As of 2026-10-23 16:27 PDT, RA trades at $11.60 on NASDAQ/NYSE. Its 52-week range is $11.30 to $12.61.
What is the market capitalisation of RA?
RA has a market capitalisation of $640.95M on NASDAQ/NYSE.
What is the P/E ratio of RA?
RA trades at a trailing price-to-earnings (P/E) ratio of 9.83. Its price-to-book (P/B) ratio is 0.81.
What is the return on equity (ROE) of RA?
RA has a return on equity (ROE) of 7.78%.
Is RA a good stock to buy?
This page provides a data-driven analysis of RA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.